ClinicSpeak: PML and dimethyl fumarate (Tecfidera)
October 24, 2014 How should we deal with the PML risk in patients on Tecfidera? #ClinicSpeak #MSBlog #MSResearch “Progressive multifocal…
With Regards to Tecfidera
After the recent news of PML being found in a Tecfidera patient from Europe, a health care clinician wanted to…
Stuart Schlossman
Biogen’s Tecfidera sales miss estimates; confirms first PML case
(Reuters) – Biogen Idec Inc said on Wednesday sales of its big-selling new multiple sclerosis drug Tecfidera fell short of…
Stuart Schlossman
Results from Two Phase III Studies (7mg and 14mg dosages) Added to U.S. Label of Genzyme’s Aubagio
Once-daily Aubagio is the only oral treatment to significantly slow progression of disability in two Phase III studies of patients…
Stuart Schlossman
Tecifdera Efficacious for Relapsing-Remitting Multiple Sclerosis
Biogen Idec announced five-year results from the ENDORSE Phase 3 extension study with Tecfidera(dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis (RRMS). ENDORSE is…
Stuart Schlossman
Teriflunomide (AUBAGIO) Is Now the First Oral Regimen Proven to Delay Onset of Clinically Definite Multiple Sclerosis
Author: Michael R. Page, PharmD, RPh In a recent phase III trial published on September 2, 2014, in the journal Lancet…
Stuart Schlossman
Genzyme to Feature Multiple Sclerosis Pipeline and Present New Data on Aubagio and Lemtrada at ECTRIMS
– Genzyme Pursuing Innovative Approaches for Investigational Treatments Targeting Relapsing and Progressive Forms of MS – – More Than 25…
Stuart Schlossman
A Positive Impact on 3 Key Measures of Multiple Sclerosis (MS) Disease Activity Versus Placebo at Week 108 with AUBAGIO 14 mg1,2
Hear from Our Expert Listen to an engaging and informative audio presentation by Dr. Steven Cavalier, Senior Medical Director for…
Stuart Schlossman
MS Oral Therapy, Tecfidera, is now being reimbursed in Alberta, Canada
Mississauga, ON – August 7, 2014 – Biogen Idec Canada announces today that Alberta Health will now reimburse TECFIDERA™ (dimethyl…
Stuart Schlossman
MS patients in B.C. now have access to two oral treatments subsidized by the provincially funded drug program Pharmacare.
New oral treatments available to multiple sclerosis patients They mark an advance over injections and IV, says advocate BY ERIN…
Stuart Schlossman
